Board of Directors

Clinical Trials Ontario has established a skills-based Board of Directors to guide the organization in this critical endeavour.

Arthur Slutsky

Chair

Vice-President, Research
St. Michael’s Hospital

Mark Lundie

Vice-Chair and Secretary

Director, Medical Affairs, Rare Diseases
Pfizer Canada Inc.

Raphael Hofstein

Treasurer

President & Chief Executive Officer
MaRS Innovation

Tina Ceroni

Clinical Trial Participant

Anne Ellis

Associate Professor and Chair, Division of Allergy & Immunology, Department of Medicine
Queen’s University

Ed Dybka

President
AstraZeneca Canada Inc.

Raphael Saginur

Chair
Ottawa Health Science Network Research Ethics Board

Clive Ward-Able

Former Executive Director, R&D
Amgen

James Wilson

President
Brancorth Medical Inc.